Download video

ARC Talks Webinar: Approaches to Treating Relapsed and Refractory AL Amyloidosis

812 views

Amyloidosis Research Consortium (ARC)

7 years ago

ARC Talks Webinar: Approaches to Treating Relapsed and Refractory AL Amyloidosis

ARC Talks Webinar: Approaches to Treating Relapsed and Refractory AL Amyloidosis

X28_AS 2
34:00
X28_AS 2
by ACRF Doco
EuroBioC 2025 Short Talks 2, Day 2
1:25:34
EuroBioC 2025 Short Talks 2, Day 2
by Bioconductor
ARC System | R2C2
0:51
ARC System | R2C2
by R2C2
CONTACT-03: subgroup analysis of 2L cabozantinib ± atezolizumab in aRCC
2:13
CONTACT-03: subgroup analysis of 2L cabozantinib ± atezolizumab in aRCC
by VJOncology
What’s New in 22q ? Podcast Episode 11 - Oxytocin Seals Brain Barriers in 22q11.2DS Mice
13:07
What’s New in 22q ? Podcast Episode 11 - Oxytocin Seals Brain Barriers in 22q11.2DS Mice
by 22q11 Europe
OriGene Podcast Episode 2
9:03
OriGene Podcast Episode 2
by OriGene Technologies Inc.
VERITAC-2: vepdegestrant versus fulvestrant in ER+\/HER2- breast cancer
1:35
VERITAC-2: vepdegestrant versus fulvestrant in ER+\/HER2- breast cancer
by VJOncology
REGONEXT: 2L regorafenib in patients with unresectable HCC who have progressed on atezo-bev
1:15
REGONEXT: 2L regorafenib in patients with unresectable HCC who have progressed on atezo-bev
by VJOncology